Sarepta Stops Stop Shipments of Muscular Dystrophy Gene Therapy After Second Patient Death
A patient has died after receiving Sarepta Therapeutics’ approved gene therapy for Duchenne muscular dystrophy —…
A patient has died after receiving Sarepta Therapeutics’ approved gene therapy for Duchenne muscular dystrophy —…
InSilicoTrials, a health tech company that develops AI-based simulation to predict drug safety and efficacy in…
Something needs to change here, but first, give yourself permission to be (privately) annoyed, frustrated, or…
Former Senior Beauty & Lifestyle Editor Jamie Schneider is the former Senior Beauty Editor at mindbodygreen….
Omeprazole oral capsule is a prescribed medication solely offered in its generic form, lacking a branded…
Flomax is utilized to address the symptoms of urinary hesitancy associated with benign prostatic hyperplasia (BPH)….
My Italian grinder sliders are a major hit for any occasion! I love whipping up a…
Every beauty professional has their nonnegotiable steps. In our series Like a Pro, we tap experts for…
No doubt highlighters are a clean beauty mainstay; after all, they’re all about glowy, healthy-looking skin…
In Scottsdale, we know how serious skin cancer is. It affects your health and how you…
Most people check for skin cancer symptoms by looking for abnormal growths or changes in the…
Scheduling appointments can be a significant challenge for patients, often forcing them to navigate multiple portals,…
Tombot, a California-based robotics company that makes a robotic puppy that serves as a companion animal…
AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial…
Michael Needham, principal at Efficio, a global supply chain procurement consultancy, sat down with MobiHealthNews to…
Ellipsis Health, a company using AI voice agent technology, announced it has raised $45 million in…
Historically, maintenance strategies for critical systems relied heavily on fixed schedules, known as preventive maintenance. And…
Psychiatrists often face a frustrating truth: half of all patients with major depressive disorder don’t respond…